['venous thromboembolism']
['dabigatran']

        Inclusion criteria:

          -  Neonates and infants with aged < 12 months at Visit 1

          -  Objective diagnosis of VTE

          -  End of planned treatment course with anticoagulant therapy as per standard of care at
             the investigator site.

          -  Written informed consent provided by the patient's parent(s) (or legal guardian)
             according to local regulations at Visit 1.

        Exclusion criteria:

          -  Weight less than 3 kg at Visit 1

          -  Conditions associated with an increased risk of bleeding

          -  renal dysfunction

          -  hepatic disease

          -  Anemia or thrombocytopenia at screening
      